AU1606799A - Recombinant vaccinia constructs expressing feline il-2, compositions and methodsof use thereof - Google Patents

Recombinant vaccinia constructs expressing feline il-2, compositions and methodsof use thereof

Info

Publication number
AU1606799A
AU1606799A AU16067/99A AU1606799A AU1606799A AU 1606799 A AU1606799 A AU 1606799A AU 16067/99 A AU16067/99 A AU 16067/99A AU 1606799 A AU1606799 A AU 1606799A AU 1606799 A AU1606799 A AU 1606799A
Authority
AU
Australia
Prior art keywords
methodsof
compositions
recombinant vaccinia
constructs expressing
expressing feline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU16067/99A
Inventor
Russell R. Gettig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Virogenetics Corp
Original Assignee
Virogenetics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virogenetics Corp filed Critical Virogenetics Corp
Publication of AU1606799A publication Critical patent/AU1606799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU16067/99A 1997-12-09 1998-12-07 Recombinant vaccinia constructs expressing feline il-2, compositions and methodsof use thereof Abandoned AU1606799A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98720497A 1997-12-09 1997-12-09
US08987204 1997-12-09
PCT/US1998/025207 WO1999029864A1 (en) 1997-12-09 1998-12-07 Recombinant vaccinia constructs expressing feline il-2, compositions and methods of use thereof

Publications (1)

Publication Number Publication Date
AU1606799A true AU1606799A (en) 1999-06-28

Family

ID=25533100

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16067/99A Abandoned AU1606799A (en) 1997-12-09 1998-12-07 Recombinant vaccinia constructs expressing feline il-2, compositions and methodsof use thereof

Country Status (2)

Country Link
AU (1) AU1606799A (en)
WO (1) WO1999029864A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2918598T3 (en) * 2007-02-28 2019-04-29 The Govt Of U S A As Represented By The Secretary Of The Dept Of Health And Human Services Brachyury polypeptides and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5833975A (en) * 1989-03-08 1998-11-10 Virogenetics Corporation Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
JP3822261B2 (en) * 1994-09-09 2006-09-13 財団法人癌研究会 Cancer gene therapy

Also Published As

Publication number Publication date
WO1999029864A1 (en) 1999-06-17

Similar Documents

Publication Publication Date Title
AU1123499A (en) Hair care composition
AU2287297A (en) Hair care compositions
AU9556098A (en) Personal care compositions
AU7496498A (en) Skin care compositions
AUPP494798A0 (en) Protective protein formulation
AU1656197A (en) Improved bipolar scissors
AU3415297A (en) Thickened personal care composition
AU2572499A (en) Human hairless gene, protein and uses thereof
AU7462396A (en) Skin care compositions
AU1592099A (en) Skin care composition
AU3419197A (en) Hair care composition
AU1750997A (en) Obesity protein formulations
AU1705197A (en) Obesity protein formulations
AU9017598A (en) Human frezzled-like protein
AU3359199A (en) Hair care compositions
AU1507499A (en) Human nap1 protein
AU6774198A (en) Human rab protein, srab
AU2243997A (en) Obesity protein formulations
AU1747297A (en) Obesity protein formulations
AU1606799A (en) Recombinant vaccinia constructs expressing feline il-2, compositions and methodsof use thereof
AU3195099A (en) Hair care compositions
AU2976397A (en) Novel feline cytokine protein
AU6780998A (en) Human tumorigenesis associated protein, htap
AU6050198A (en) Novel human cystatin-like protein
AU4992099A (en) Human presenilin-associated protein

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase